Which has the lower trailing P/E, BMY or PFE?

BMY has the lower trailing P/E: BMY trades at 17.57 and PFE at 18.83. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, BMY or PFE?

Over the past five years, PFE grew revenue faster — BMY at a 2.52% CAGR versus PFE at 8.22%.

Does BMY or PFE pay a bigger dividend?

BMY yields 4.00% and PFE yields 6.97% based on trailing dividends and the latest price.

Is BMY or PFE more profitable?

BMY runs the higher net margin — BMY at 15.01% versus PFE at 11.83%.

How have BMY and PFE total returns compared?

Over the past 10 years, BMY delivered 2.02% and PFE delivered 1.55% annualized total return. Past performance doesn't predict future results.

Bristol-Myers Squibb Company (BMY) vs Pfizer Inc. (PFE)

A side-by-side comparison of Bristol-Myers Squibb Company and Pfizer Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of July 28, 2026. Differences are shown without an overall score or investment verdict.

BMY

Bristol-Myers Squibb Company

$129.88B

$63.60HealthcareDelayed quote: Jul 28, 2026, 4:00 PM EDT

PFE

Pfizer Inc.

$143.91B

$25.25HealthcareDelayed quote: Jul 28, 2026, 4:02 PM EDT

Total return — BMY vs PFE

growth of $100 · dividends reinvested · last 30y

BMY +790.3%PFE +562.5%BMY compounded faster

BMY PFE

BMY vs PFE: by the numbers

•PFE is the larger company ($143.91B vs $129.88B market cap).
•BMY trades at the lower trailing earnings multiple (17.57 vs 18.83 P/E), one valuation lens rather than an overall verdict.
•BMY converts more revenue to profit (15.01% vs 11.83% net margin).
•PFE grew revenue faster over the past five years (8.22% vs 2.52% CAGR).
•PFE pays the higher dividend yield (6.97% vs 4.00%).

Metrics side by side

Valuation

Metric	BMY	PFE
P/E ratio	17.57	18.83
Forward P/E	9.86	8.38
P/S ratio	2.64	2.23
P/B ratio	6.37	1.57
PEG ratio	1.87	N/A
EV / EBITDA	10.34	9.72
FCF yield	9.31%	6.71%

Profitability

Metric	BMY	PFE
Gross margin	68.75%	69.35%
Operating margin	25.67%	23.45%
Net margin	15.01%	11.83%
ROE	36.25%	8.31%
ROIC	13.90%	8.84%

Dividends

Metric	BMY	PFE
Dividend yield	4.00%	6.97%
Payout ratio	72.25%	126.47%

Growth (annualized)

Metric	BMY	PFE
Revenue CAGR (5Y)	2.52%	8.22%
EPS CAGR (5Y)	9.38%	-3.78%
FCF CAGR (5Y)	-2.50%	-3.79%
Total return CAGR (5Y)	2.73%	-5.21%

Frequently asked

Which has the lower trailing P/E, BMY or PFE?: BMY has the lower trailing P/E: BMY trades at 17.57 and PFE at 18.83. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, BMY or PFE?: Over the past five years, PFE grew revenue faster — BMY at a 2.52% CAGR versus PFE at 8.22%.
Does BMY or PFE pay a bigger dividend?: BMY yields 4.00% and PFE yields 6.97% based on trailing dividends and the latest price.
Is BMY or PFE more profitable?: BMY runs the higher net margin — BMY at 15.01% versus PFE at 11.83%.
How have BMY and PFE total returns compared?: Over the past 10 years, BMY delivered 2.02% and PFE delivered 1.55% annualized total return. Past performance doesn't predict future results.

Go deeper

Full BMY analysis Full PFE analysis Interactive comparison tool

Dig into the metrics

Bristol-Myers Squibb P/E ratio Pfizer P/E ratio Bristol-Myers Squibb dividend yield Pfizer dividend yield Bristol-Myers Squibb ROE Pfizer ROE Bristol-Myers Squibb operating margin Pfizer operating margin Bristol-Myers Squibb revenue growth Pfizer revenue growth Bristol-Myers Squibb free cash flow Pfizer free cash flow

Bristol-Myers Squibb & Pfizer appear in these rankings

Highest Dividend Yield Stocks Highest ROE Stocks Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified July 28, 2026.